Mody

(redirected from Maturity onset diabetes of the young)
Also found in: Medical, Wikipedia.
Related to Maturity onset diabetes of the young: maturity onset diabetes of the young type 2

Mod´y


a.1.Fashionable.
References in periodicals archive ?
Diabetologists have also been aware of the transmissibility of diabetes in families, as in the cased of maturity onset diabetes of the young (MODY)11.
Characteristics of maturity onset diabetes of the young in a large diabetes center.
Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
Owen, "Diagnosis and management of maturity onset diabetes of the young (MODY)," BMJ, vol.
Common variants in maturity onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns.
Abbreviations CVD: Cardiovascular diseases CHD: Coronary heart disease GDM: Gestational diabetes mellitus GIP: Glucagon intestinal peptide GLP: Glucagon-like peptide 1 IADPSG: International association of diabetes and pregnancy study groups MODY: Maturity onset diabetes of the young ORs: Odds ratios OXLDL: Oxidized LDL SNPs: Single nucleotide polymorphisms T2DM: Type 2 diabetes mellitus TG: Triglycerides.
LAN HAM, M.D.., January 31, 2013--Scientists have for the first time generated human induced pluripotent stem cells from patients with an uncommon form of diabetes, maturity onset diabetes of the young (MODY).
[30,31] Although this approach had proven extremely successful in identifying rare genetic variants of strong effects for single-gene disorders such as maturity onset diabetes of the young (MODY)[32], but proved limited in unveiling common genetic variants that underlie polygenic diseases.
Maturity Onset Diabetes of the Young, or MODY, is worth considering in white youth who are pancreatic autoantibody-negative and have a history of parental non-type 1 diabetes.
Progress in our understanding of the molecular bases and pathophysiology of maturity onset diabetes of the young (MODY) (3) and neonatal diabetes (4,5) has allowed introduction of oral medications and freed many children from the discomfort and expense of insulin therapy (6), and the continuing development of new drugs and new technology for the treatment and monitoring of diabetes has added many valuable tools for our care of this disease.
Her condition - maturity onset diabetes of the young - means that without medication she could suffer tiredness, increased susceptibility to infections or even damage to her vision and kidneys.

Full browser ?